Safety and food effect of Hemay5259 in healthy adults
This study tests a new sustained-release tablet called Hemay5259 in healthy volunteers. It checks how safe the drug is, how your body processes it, and whether food affects its absorption.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old and in good general health.
- Your body mass index (BMI) must be between 18 and 30, and you must weigh at least 50 kg (men) or 45 kg (women).
- You cannot have a history of depression or other significant medical conditions.
- You cannot be taking prescription medications (except birth control or occasional pain relievers) in the 2 weeks before the study.
- You must be a non-smoker (or smoke very little) and not drink more than 14–21 alcoholic drinks per week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.
This trial tests a new investigational drug called SYH2056 in healthy volunteers to see if it is safe and how the body handles it. It also checks how food affects the drug. Participating may help determine if the drug can be developed for future patients.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests how a new drug called RNK08954 is processed by the body after food, and how it is eliminated. It is for healthy adults who want to help researchers understand the drug's safety and effects.
This study tests a new oral medication, HY8931, in healthy adults to see if it is safe and how the body processes it. You will be closely monitored during the trial.
Hear when a new Pharmacokinetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.